FDA Announces Revised Draft Guidance on Prescription Drug User Fee Waivers, Reductions, and Refunds

Summary

The FDA is releasing a revised draft guidance for industry on user fee waivers, reductions, and refunds for prescription drugs, providing recommendations for applicants seeking to waive or reduce user fees.